So far, no significant hypoglycaemia signal has been seen, likely because GLP-1 and GIP agonism counterbalance glucagons glucose-raising effect, but this remains an area of ongoing surveillance
Management for this group includes attention to hormone balance , potentially including hormone replacement therapy alongside tirzepatide
J Urol 1996
One theoretical concern is that the same angiogenesis-promoting properties that aid healing could potentially have unintended effects
See your latest numbers with trend arrows showing whether you're heading up, down, or steady
"Same price, every dose, no hidden fees." According to TeleHealth Med's published pricing, the subscription cost does not increase as the prescribed dose is titrated upward during treatment